Result
-€3.5m -€3.5m
From profit to loss in 2023, after a profit of €575,833 in 2022.
IQVIA MedTech NV
Lifetime
17 annual accounts with figures on one time axis, 18 filings since 2006Turnoverpeak €15.6m (2022)
€5.6m▼ 64.0%
Resultlowest -€3.5m (2023)
-€3.5m▼ €4.1m
Equitypeak €34.2m (2023)
€34.2m▲ 205%
Debts
€18.0m▲ 40.8%
Staffpeak 45.8 FTE (2018)
31.6 FTEunchanged
Board8 names since 2022
3 directorsEmmanuel Vanderhaegen and 2 others
Owners4 names in the annual accounts
100%IQVIA RDS & INTEGRATED SERVICES BELGIUM
Documentsfilings and deeds
23-12-2024145 days late
2023financial year
Turnover from €15.6m to €5.6mLoss of €3.5mRegistered office moved from Antwerp to Berchem 03-08Resignation: Frank Swaelerıs (director) 01-03Equity from €11.2m to €34.2mDebts from €12.8m to €18.0m
Key points
from the 2023 annual accountsInvestments
€17.6m 1251.5 × depreciation
Green is investment, beige is depreciation.
Payment terms
692 days to suppliers
IQVIA MedTech NV pays its suppliers 361 days later than in 2022. Customers pay 824 days later.
Filings
18 annual accounts 20 filings, 462 days past the deadline
2024 accounts not filed: deadline was 31-07-2025.
At the same address
24 companies
Position in the sector
-€3.5m
Lower net result than 95% of companies in architecture and engineering. Sector median €35,887 · 1,097 companies.
2023 figures too old to score
Bankruptcy probability
No current score
Figures too old
The latest figures are for FY 2023. They are too old for a current score.
Filing: At least two annual filings are missing
Bankruptcy probability within 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 690 companies (NACE 71, small).
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 1.7%
01-2025: 0.6%▼ -1.1 percentage points vs 12-2024
02-2025: 0.6%● unchanged vs 01-2025
03-2025: 0.6%● unchanged vs 02-2025
04-2025: 0.6%● unchanged vs 03-2025
05-2025: 0.5%▼ -0.1 percentage points vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.5%● unchanged vs 06-2025
08-2025: 0.7%▲ +0.2 percentage points vs 07-2025
09-2025: 0.4%▼ -0.3 percentage points vs 08-2025lowest value
10-2025: 0.5%▲ +0.1 percentage points vs 09-2025
11-2025: 0.6%▲ +0.1 percentage points vs 10-2025
12-2025: 0.7%▲ +0.1 percentage points vs 11-2025
01-2026: 1.5%▲ +0.8 percentage points vs 12-2025
02-2026: 1.5%● unchanged vs 01-2026
03-2026: 1.5%● unchanged vs 02-2026
04-2026: 1.3%▼ -0.2 percentage points vs 03-2026
05-2026: 1.3%● unchanged vs 04-2026
06-2026: 1.3%● unchanged vs 05-2026
07-2026: 1.3%● unchanged vs 06-2026
08-2026: 2.1%▲ +0.8 percentage points vs 07-2026highest value
09-2026: 2.1%● unchanged vs 08-2026highest value
10-2026: 2.1%● unchanged vs 09-2026
11-2026: 2.1%● unchanged vs 10-2026
Financial strength, FY 2023Average
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 8 filingsPosition against the passed deadline
31-12-2024 year end31-07-2025 deadline05-11-2026 today
raises risk · 2023 accounts filed 145 days late
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 23-12-2024, 145 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 8 filingsDeviation from the deadline
2025
not filed
2024
not filed
2023
145 days late
2022
592 days late
2021
3 days early
2020
26 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 141 days after the deadline. In the sector (NACE 71), the median for financial year 2024 was 8 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (1)
Board and ownership
MB
Mazars Bedrijfsrevisoren CV
Auditor, Peter Lenoir
- IQVIA RDS & INTEGRATED SERVICES BELGIUM 100%score 86equity €2.4m (2025) · 2025 annual accounts of IQVIA RDS & INTEGRATED SERVICES BELGIUM
Recent changes
Registered office moved from Antwerp to Berchem
New registered office: The Sage Antwerp, Berchemstadionstraat 78, 2600 Berchem · Previous registered office: Justitiestraat 6B 2018 Antwerpen · Resignations: Wouter Tack (director) and Brad Thomas (director) · Board meeting of 06-07-2023 · Gazette deed
Resignation: Frank Swaelerıs (director)
Appointment: Emmanuel Vanderhaegen (director) · Director discharge: Frank Swaelerıs · General meeting of 01-02-2023 · Gazette deed
Appointment: Mazars Bedrijfsrevisoren CV (statutory auditor)
Permanent representative: Peter Lenoir · Board meeting of 27-07-2022 · Gazette deed
Resignation: Richard Farris (director)
Appointment: Brad Thomas (director) · General meeting of 30-05-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | Turnover | EBIT margin | Solvency | Staff |
|---|---|---|---|---|
| IQVIA MedTech NV Antwerp | €5.6m | -96.2% | 65.5% | 31.6 |
| IDEXX LABORATORIES Brussels | €19.6m | 4.0% | 96.5% | 17.2 |
| HRD ANTWERP Antwerp | €4.3m | -13.6% | 41.5% | 37.9 |
| TS Holding Balen | €10.7m | 24.9% | 15.6% | 10.1 |
| CAMIN CARGO CONTROL NW EUROPE Antwerp | €7.6m | -4.5% | -8.9% | 32.6 |
| INTERNATIONAL POST CORPORATION Brussels | €11.2m | -0.3% | 55.9% | 64.9 |
| CERTIFER BELGORAIL Brussels | €18.9m | 13.2% | 71.0% | 29.1 |
Grey: the largest companies of the sector (architecture and engineering (NACE 71)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as IQVIA MedTech NV: other technical testing and analysis (NACE 71209). They are comparable in size and age: total assets between €14m and €53m, founded between 1989 and 2012.
Official details
Source: KBO- Status
- Active since 18-05-2005Normal situation
- Registered office
- 25 active companies are registered at this addressSource: KBO register, as of 5 November 2026.
- Activity
- Other technical testing and analysisNACE 71209and 3 others
- Joint committees
- 200Auxiliary committee for white-collar workers
- 100Auxiliary committee for blue-collar workers · annual accounts 2023
- Establishment unit
- 2.147.958.8922600 Antwerp, since 12-07-2005
- Financial year end
- 31 December
- Peppol
- Reachable
Insights on IQVIA MedTech NV
IQVIA MedTech NV has existed since 2005. Turnover fell from €15.6m in 2022 to €5.6m in 2023.
Solvency rose in 2023 from 46.7% to 65.5%.
IQVIA RDS & INTEGRATED SERVICES BELGIUM holds all the shares. In 2023, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about IQVIA MedTech NV
- What is the company number of IQVIA MedTech NV?
- The company number of IQVIA MedTech NV is 0873.863.003. The VAT number is the same number with BE in front: BE 0873.863.003.
- Where is IQVIA MedTech NV based?
- The registered office is at Berchemstadionstraat 78, 2600 Antwerp.Company details
- What does IQVIA MedTech NV do?
- According to the KBO register, the main activity is other technical testing and analysis (NACE 71209).
- What is the legal form of IQVIA MedTech NV?
- IQVIA MedTech NV is a public limited company (NV).
- When was IQVIA MedTech NV founded?
- IQVIA MedTech NV was founded on 18-05-2005.
- Is IQVIA MedTech NV still active?
- Yes, IQVIA MedTech NV is an active enterprise in the KBO register.
- How many employees does IQVIA MedTech NV have?
- IQVIA MedTech NV had an average of 31.6 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- Which joint committee does IQVIA MedTech NV fall under?
- In its 2023 annual accounts, IQVIA MedTech NV states joint committees 200 (Auxiliary committee for white-collar workers) and 100 (Auxiliary committee for blue-collar workers).
- What is the turnover of IQVIA MedTech NV?
- The turnover of IQVIA MedTech NV was €5.6m in financial year 2023, according to the filed annual accounts.
- Is IQVIA MedTech NV profitable?
- In financial year 2023, IQVIA MedTech NV made a loss of €3.5m.
- Where can I find the annual accounts of IQVIA MedTech NV?
- IQVIA MedTech NV filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.